Bill C-2 (39th Parliament, 1st Session) committee  Thank you, Mr. Chairman, ladies and gentlemen. Thank you very much for inviting Genome Canada to come here in front of this committee on Bill C-2. First, you will find that we have provided you with a package of all of our information, and we have provided you with one table. To

Bill C-2 (39th Parliament, 1st Session) committee  As far as Genome Canada is concerned, in our new agreement with Industry Canada, the Auditor General may audit our books at the request of the minister.

Bill C-2 (39th Parliament, 1st Session) committee  As far as Genome Canada is concerned, we solved that problem a long time ago. The names of reviewers are not disclosed. We disclose the names of all members of the panel. The research scientist does not know who will assess and validate his or her file. There is an advantage in t

Bill C-2 (39th Parliament, 1st Session) committee  Absolutely. We do not have any problem with Bill C-2. Genome Canada has no problem with the government asking it for information. I would like to return to the issue of confidentiality. I believe this is not being approached in the proper way. For Genome Canada, the concept of c

Finance committee  Perfect. Thank you, Mr. Chairman. Good morning everybody. I am delighted to have the opportunity to meet with the members of the Standing Committee on Finance and to provide an overview of some of Genome Canada's most important accomplishments. Over the next few minutes, I wil

Finance committee  To answer your question regarding $380 million requested, a strategic plan was prepared for Industry Canada and, upon request of the department, as is the case for any budget or grant application. The costs are assessed line by line, request by request. Right now, the financial

Finance committee  It's important from an economic standpoint. Let's say Genome Canada receives $1 from the federal government. We are then under obligation to obtain an equivalent sum from other sources. We receive $600 million over six years and we collected $840 million from other sources. Beli

Finance committee  Genome Canada has 17 employees. It's an investment fund.

Finance committee  We have about 100 projects, and over 2,000 people are directly affected by the contributions of Genome Canada.

Finance committee  Thank you, Mr. McCallum. Up until now, our government representatives seem to be saying that the intention is to support Genome Canada, but the issue is how to fund it? That depends on senior officials at the Department of Finance. As far as the brain gain is concerned, I can a

Finance committee  Yes, that is right.

Finance committee  It is for a minimum of 10 years. We started in 2000. All my colleagues in the pharmaceutical and biopharmaceutical industry who are here know that it takes between 10 and 12 years before you can think about seeing a return on an investment. We have had some returns on investment

Finance committee  Welcome to Canada. You have Genome Canada, which is the main house, I would say, and you have six other genome centres across Canada, because there are differences in culture and differences in application. You won't do fisheries in Quebec, you'll do pharmaceuticals.

Finance committee  As for the money, we asked for $380 million. We will raise $450 million on top of that, and the money will be distributed to all the regions.

Finance committee  Based on excellence.